News & Perspective

Nov 30, 2009

Nov 24, 2009

Nov 24, 2009

Novartis unveils US cell-based flu vaccine plant

(CIDRAP News) – The era of cell-based influenza vaccine production in the United States seemed to move closer today as Novartis unveiled its new, nearly billion-dollar manufacturing plant in Holly Springs, N.C., but onshore production and marketing of cell-based vaccines remains a few years away.

Nov 04, 2009

Nov 04, 2009

H1N1 FLU BREAKING NEWS: OTC antivirals, Ukraine aid, Amazon tribe struck, pain relievers and vaccine, cat has H1N1

 

Norway OKs OTC antiviral salesTo ease response to the H1N1 pandemic, Norway is allowing over-the-counter sales of oseltamivir (Tamiflu) and zanamivir (Relenza), the Associated Press (AP) reported. The new policy starts tomorrow and is in effect until the middle of 2010. Norway has ordered 9.4 million doses of vaccine, but the manufacturer has reportedly not produced enough to meet demand.

Nov 02, 2009

Nov 02, 2009

WHO sends team to Ukraine as flu cases rise

(CIDRAP News) – The World Health Organization (WHO) confirmed yesterday that it was sending a team of experts to help the government of Ukraine, where it said more than 2,300 people have been hospitalized for what is suspected to be pandemic H1N1 influenza and 38 have died.

Oct 23, 2009

Oct 23, 2009

More clouds in H1N1 vaccine supply picture

(CIDRAP News) – Questions about the tardy US supply of pandemic H1N1 vaccine have increased with the report that most of Novartis's doses may not reach the country until early in 2010 and a European regulatory recommendation that may have implications for the global vaccine supply.

Oct 12, 2009

Oct 12, 2009

Studies point up pandemic demand on critical care resources

(CIDRAP News) – A collection of new studies is demonstrating once again the ability of the pandemic H1N1 virus to make some people desperately sick and is raising questions about the potential strain on critical-care resources this fall and winter.

Pages

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»